U.S. Markets open in 3 hrs 16 mins

$4.8B Roche-Spark deal delayed, once again

John George
$4.8B Roche-Spark deal delayed, once again

Roche and Spark Therapeutics are delaying their $4.8 billion deal for a third time to again give federal regulators more time to review the proposed sale of the Philadelphia gene therapy company.